Vibrio cholerae is the causative agent of the severe dehydrating diarrhoeal disease cholera [Reference Kaper, Morris and Levine1]. Traditionally, serological classification of V. cholerae is based on the somatic O antigens and requires about 206 antisera [Reference Shimada2], whereas O139 serogroup is associated with cholera epidemics and O1 serogroup with cholera epidemics and pandemics [Reference Sack3, Reference Bhattacharya4]. The current classification of V. cholerae distinguishes two O1 serotypes, Ogawa and Inaba. Apart from these serotypes, there is a third rare and unstable serotype (Hikojima), which agglutinates with both anti-Inaba and anti-Ogawa antisera . Each serotype has been divided into classical and El Tor biotypes [Reference Kaper, Morris and Levine1], although two additional variants have been proposed, i.e. hybrid and El Tor variant [Reference Raychoudhuri6]. V. cholerae has been a part of human life for millennia. Throughout history, there have been seven pandemics caused by V. cholerae O1 serogroup strains where the human population has been decimated in the affected geographical areas.
In 1992 a new serogroup named O139 appeared as a result of a lateral gene transfer that replaced a region encoding the O1 antigen of the seventh pandemic V. cholerae O1 El Tor strain [Reference Comstock7]. Since then, both serogroups have co-existed. More than 600 outbreaks have been reported in recent years [Reference Griffith, Kelly-Hope and Miller8], of which about 83% occurred in Sub-Saharan Africa and South East Asia, whereas in Europe cholera arises mainly as sporadic cases. V. cholerae strains which cause cholera carry the cholera toxin (CT) and toxin co-regulated pilus (TCP), coded by the ctxA and tcpA genes, respectively [Reference Herrington9, Reference Singh10]. Non-O1/O139 serogroups may harbour virulence genes, indicating toxigenic potential from environmental sources [Reference Singh10, Reference Teh, Chua and Thong11]. Given the fact that most virulence genes in V. cholerae are located in mobile elements, new pathogenical variants could emerge from the strains of these serogroups [Reference Chakraborty12].
Recent economic, technological and social globalization has increased communications between countries throughout the world, and as a consequence easy dissemination of pathogenic agents is enabled. This fact, together with the possibility of using microorganisms in acts of bioterrorism, causes a real threat to public health. Due to the virulence and ease of dissemination of V. cholerae, it can be used as a biological weapon agent [Reference Ashford, Kaiser and Bales13]. Therefore, it is crucial to have a deep knowledge about V. cholerae strains in order to perform epidemiological investigations and forensic studies. Several molecular methods have been used for identification and typing of V. cholerae strains: enterobacterial repetitive intergenic consensus (ERIC) sequence polymerase chain reaction (PCR), box elements PCR (BOX-PCR), amplified fragment-length polymorphism (AFLP) [Reference Singh10], single nucleotide polymorphism (SNP) [Reference Danin-Poleg14], random amplified polymorphism DNA (RAPD) [Reference Scracia15], pulsed-field gel electrophoresis (PFGE) [Reference Kam16–Reference Stine18], multi-locus sequence typing (MLST) [Reference Danin-Poleg14, Reference Garg19, Reference Kotetishvili20] and variable number tandem repeat (VNTR) analysis (MLVA). The latter is a high-resolution method based on the tandem repeat analysis in multiple loci, used for genotyping and trace-back studies [Reference Belkum21]. Clinical and environmental V. cholerae strains have been analysed by this method to study the relationship among isolates [Reference Teh, Chua and Thong11, Reference Stine18, Reference Olsen22]. Phenotypic features (characteristics) of V. cholerae have also been established [Reference Scracia15, Reference González Fraga23, Reference Okoh and Igbinosa24].
In this study, phenotypic and genetic analysis of 111 clinical and environmental O1, O139, and non-O1/O139 serogroup strains from different geographical areas was performed. Relationship among the strains was assessed by the combinations of obtained phenotypic and genetic data.
The V. cholerae strains used in this work were isolated between 1978 and 2008 from different countries (see Supplementary Table S1, available online). Thirty-one strains were clinical isolates, 75 were environmental and five of unknown origin. Strains included O1 (28 Ogawa, 12 Inaba, 1 Hikojima), O139, O141 and non-O1/O139 serogroups. Seventeen strains of V. cholerae out of the 111 included in this study were previously characterized by means of phenotypic and genetic analysis [Reference Olsen22, Reference Usera25]. Viable bacteria and DNA preparations were obtained from the culture collections of the Biological Defence Unit, Instituto Tecnológico La Marañosa, San Martin de la Vega (Madrid, Spain) (ITM), Military Institute of Hygiene and Epidemiology (Pulawy, Poland) (MIHE) and Norwegian Defence Research Establishment (Kjeller, Norway) (FFI). DNA preparation and cell culture of V. cholera were performed by the above laboratories or kindly provided by Dr A. Echeita from the Institute of Health Carlos III (Madrid, Spain). Bacterial strains were streaked onto thiosulphate citrate bile salts sucrose (TCBS) agar plates and incubated for 24 h at 37°C (Oxoid, Spain), before being grown in tryptic soy broth (TSB; Oxoid, Spain).
Extraction of DNA
DNA was extracted using the QIAmp DNA Blood Mini kit (Qiagen GmbH, Germany) according to the manufacturer's protocols. Purified DNA was quantified using the NanoDrop ND 1000 spectrophotometer (NanoDrop Technologies Inc., USA).
Strains were identified as V. cholerae using the microbiological culture analyser AutoSCAN®-4 (Siemens Healthcare Diagnostic S.L., Spain) or by classical biochemical reactions [Reference Kaper, Morris and Levine1].
The serotypes were determined by slide agglutination with polyvalent O1 and O139 antiserums, and monospecific Inaba and Ogawa antisera (Oxoid, Spain).
Standard phenotypic tests were performed for biotype confirmation: susceptibility to polymyxin B (50 U) (Oxoid, Spain), chicken erythrocytes agglutination, haemolysis of sheep erythrocytes and Voges–Proskauer test [Reference Kaper, Morris and Levine1].
In order to determine susceptibility of the strains to antimicrobial agents, the Kirby–Bauer diffusion method was performed [Reference Bauer26] using commercial antibiotic disks (Oxoid, Spain): ampicillin (10 μg), tetracycline (30 μg) or doxycycline (30 μg), trimethoprim (25 μg), gentamicin (10 μg), nitrofurantoin (300 μg), streptomicyn (10 μg) and nalidixic acid (30 μg). The Control Laboratory Standards Institute (CLSI) has established interpretative criteria for V. cholerae for the following drugs: amplicillin, chloramphenicol, tetracycline group, and folate pathway inhibitors . CLSI criteria for Enterobacteriaceae were used to interpret results of other antimicrobial susceptibility tests . Antimicrobial susceptibility to colistin (4 μg/ml) was determined with the AutoSCAN®-4 sytem (Siemens Healthcare Diagnostic S.L.). A control strain of Escherichia coli (ATCC 25922) was used for these studies.
Amplification of ctxA and tcpA genes
The virulence genes ctxA and tcpA were amplified by polymerase chain reaction (PCR) as described previously [Reference Lipp29, Reference Rivera30]. To verify the correct size, amplicons were electrophoresed in low electro-endo-osmosis 2% agarose gels stained with ethidium bromide, and visualized using UV light.
The MLVA assay was performed by the ITM and MIHE laboratories according to FFI laboratory [Reference Olsen22] procedures with the following modifications; the amplifications were performed by conventional PCR (final volume 15 μl). Primers targeting polymorphic VNTRs were labelled in the 5′-end with the following fluorescent dyes and multiplexed: VC4-NED, VC5-PET and VC9-FAM. The PCR mixture contained 10–20 ng purified DNA as template, 0·5 μm of each VC4-f/r primer, 0·2 μm of each VC5-f/r primer, 0·4 μm of each VC9-f/r primer, 1·5 mm MgCl2, 2·5 U Taq DNA polymerase, and 0·2 mm of each dNTP in the buffer provided by the polymerase manufacturer (Bioline Inc., USA). The amplification was performed with one cycle at 95°C for 5 min, 25 cycles at 95°C for 30 s, 58°C for 30 s, 72°C for 30 s, and one cycle at 72°C for 10 min using a Model 9700 thermal cycler (PE Applied Biosystems, USA). The multiplex reaction was diluted 1:100 in sterile water. Two μl of this dilution was diluted again 1:10 in HiDi formamide, containing the GeneScanTM-500 LIZ size standard (0·16 μl LIZ standard/20 μl HiDi formamide) (Applied Biosystems). The samples were analysed with the ABI PRISM 310 genetic analyser (Applied Biosystems) by the corresponding genotyping laboratory. The samples were injected into the capillary at 15 kV voltages for 2 s or 5 s and analysed for 28 min at 60°C using POP4 polymer. No variation in the sizing was observed using injection times of 2 s or 5 s with the same machine. Allele sizes were identified using GeneMapper v. 3.0 software (Applied Biosystems).
Analysis of the sequence data
In order to assign the correct allele number to the allele sizes obtained by capillary electrophoresis from the VC4, VC5 and VC9 loci (MLVA-3 assay), sequencing of several PCR fragments were performed. PCR products were purified using the QIAquick Gel Extraction kit (Qiagen Inc., Germany) and both strands of the PCR products were sequenced. Sequence reactions were performed using the BigDyeTM Terminator Cycle Sequencing kit v. 1.1 on an ABI PRISM 310 (PE Applied Biosystems). Sequence alignments were performed using ClustalW, MEGA4 software [Reference Tamura31].
Fragment size normalization and allele number assignment
In order to compare the fragment sizes obtained by capillary electrophoresis at different laboratories, it was necessary to normalize the above-mentioned fragment sizes. The MLVA-3 allele profiles from the V. cholerae strains FFIVC122, FFIVC123, FFIVC124, FFIVC125, FFIVC126 and FFIVC128 obtained at ITM and MIHE were compared with allele profiles previously obtained at FFI as reference data [Reference Olsen22]. For each locus, the difference between the allele size obtained at ITM, MIHE and FFI (in base pairs) was calculated for each strain. From these values, the average number of base pairs was calculated and subtracted from the allele sizes obtained at ITM or MIHE (see Supplementary Table S2, available online).
In order to assign an allele number to a certain allele size, a marker-specific size ladder was constructed. The DNA fragment sizes obtained by capillary electrophoresis and sequencing, as well as the number of repetitions observed in the VNTR regions, were used to construct the ladder. The average number of base pairs to be subtracted from the allele size obtained by capillary electrophoresis (see above), and the standard deviation calculated from the corresponding data (see Supplementary Table S2) were used to establish the allele size range to which the allele sizes should be assigned.
Typing and clustering analysis
The genetic relationship among the V. cholerae strains were determined by clustering analyses using Bionumerics v. 6.5 software (Applied Maths, Belgium). Unweighted pair-group method with arithmetic averages (UPGMA) and minimum spanning tree (MST) analyses were performed based on antibiotic susceptibility, biochemical test, serogroup, serotype, biotype, VNTR analysis, and virulence genes ctxA and tcpA amplification. The UPGMA analysis was based on categorical coefficients and MST was performed as a complementary analysis to the UPGMA analysis, and was constructed using the highest number of single locus variants (SLVs) as priority rule, i.e. where types that differ by only one character are linked first. No hypothetical types (missing links) were introduced as branches of the MST.
The discrimination ability of individual or combined phenotypic and genetic analysis was calculated using the Hunter–Gaston diversity index (HGDI) [Reference Hunter and Gaston32].
Thirty-three out of the 111 V. cholerae strains studied amplified the ctxA gene. Most of these were constituted by V. cholerae serotype O1 (29 O1, three O139, one non-O1/O139) (see Supplementary Fig. S1, available online). On the other hand, 86 V. cholerae strains amplified the tcpA gene, most of them being non-toxigenic of environmental origin (30 O1, three O139, 53 non-O1/O139).
Analysis of antibiotic resistance
The antimicrobial susceptibility tests performed in V. cholera strains revealed resistance (R) or intermediate resistance (I) to five or more of the eight antibiotics screened. The results observed for each antibiotic were as follows: ampicillin (R 39%, I 61%), tetracycline/doxycycline (R 3%, I 36%), trimethoprim (R 39%), gentamicin (R 8%, I 3%), nitrofurantoin (R 4%, I 60%), streptomycin (R 40%, I 62%), nalidixic acid (R 27%, I 73%), and colistin (R 27%, I 73%). Interestingly, nearly all human isolates expressed resistance to one or more antibiotics, including the isolates previously reported as susceptible [Reference Usera25].
PCR amplicons from six V. cholerae strains analysed by capillary electrophoresis revealed up to 8 bp differences among laboratories (see Supplementary Table S2). The differences in average number of base pairs for each VNTR locus observed at MIHE and ITM compared to FFI were 7.00 and 4.17 for VC4, 0.50 and 1.83 for VC5 and 2.00 and 1.83 for VC9, respectively. Therefore, data normalization was performed based on the comparison of MLVA results in all three laboratories, in order to avoid errors in the assignment of allele numbers as recommended earlier [Reference Pasqualotto, Denning and Anderson33]. This normalization is described in the ‘Fragment size normalization and allele number assignment’ section, and the results are shown in Table 1. The size distribution of the PCR amplicons observed were 155-317 (MIHE) and 182-303 (ITM) for VC4; 145-210 (MIHE) and 144-207 (ITM) for VC5, and 154-271 (MIHE) and 151-182 (ITM) for VC9. Deviation in several allele sizes was observed. In some cases, sequencing confirmed that these deviations were due to DNA fragments of intermediate size (Fig. 1).
* Allele number described previously [Reference Olsen22].
† New allele number observed in this study.
‡ Expected number of repeats.
§ Size obtained by capillary electrophoresis (in base pair) from indicated source.
¶ Fragment with known number of repeats by sequencing at FFI laboratory [Reference Olsen22].
|| Fragment with known number of repeats by sequencing in this study.
# Suspected or observed intermediate size.
Typing and clustering of V. cholerae strains by phenotypic and genetic analysis
Individual or combined phenotypic and genetic methods were used to analyse the relationship of 111 V. cholerae strains from different sources. The HGDI estimated for the phenotypic and genetic markers was analysed individually and combined (Table 2). The diversity index (DI) obtained in the MLVA-3 assay (DI =0·985) was close to the DI of a six-loci scheme reported by FFI [Reference Belkum21]. The antibiotic susceptibility assay yielded the lowest DI (0·610) of all performed assays, followed by the biochemical test (DI=0·790). Ninety-six different groups and a higher DI (0·997) were obtained when combining the MLVA-3 assay, the biochemical test and the antibiotic susceptibility test (Table 2). The UPGMA clustering analysis yielded a better clustering of strains according to source when combining these typing methods with ctxA and tcpA data.
HGDI, Hunter–Gaston diversity index.
* MLVA-3, VC4, VC5 and VC9 combined markers; BT, biochemical test; AS, antibiotic susceptibility; BT/AS, MLVA-3/BT, MLVA-3/AS, MLVA-3/BT/AS, MLV-3/BT/AS/ctxA/tcpA and MLV-3/BT/AS/ctxA/tcpA/Serogroup/Serotype/Biotype combined markers; n=111.
Combined phenotypic and genetic methods used in this study allowed discrimination of 98 strains out of a total of 111 (DI=0·997) (Table 2). The UPGMA clustering analysis resulted in a dendrogram where the strains were organized into four clusters (Supplementary Fig. S1). Cluster A1 contained 26 strains, where 24/26 were ctxA + and tcpA + human isolates from the following serogroups: O1 (n=21), O139 (n=3), non-O1/O139 (n=1) and O141 (n=1). O1 080025/FD strain (sewage water, Ceuta, Spain) was seen to be equal to O1 080025/EY and 080025/FC strains isolated from humans in Ceuta, Spain, which were associated with an outbreak in Morocco in 1990 [Reference Okoh and Igbinosa24]. The non-O1/O139 FFIVC084 (from mussels, Norway) V. cholerae strain (ctxA + and tcpA +) was situated in the dendrogram close to the clinical O139 serogroup strains (ctxA + and tcpA +). Cluster A2 included the environmental Norwegian FFIVC052 isolate (ctxA − and tcpA +), environmental isolates from Ecuador, Spain and Norway (ctxA − and tcpA −), and clinical Norwegian FFIVC136 and FFIVC137 strains (ctxA − and tcpA −). FFIVC129 V. cholera strain of unknown origin isolated in Spain in 1979 established an ‘outgroup’ of clusters A1 and A2. This strain resulted in a unique MLVA-3 profile with atypical biochemical characteristics. Cluster B1 included 59 non-O1/O139 strains isolated from Poland and from Baltic water, O1 serogroup 13/154 strain (clinical, India) and O1 serogroup 21/635 strain (clinical, unknown geographical origin). Fifty-three out of 61 strains were ctxA − and tpcA +, seven were ctxA − and tcpA + and one was ctxA + and tcpA +. Cluster B2 contained six O1 serogroup strains (ctxA + and tpcA +), one from an unknown source and five of human origin. O1 serogroup 14/2002/S V. cholera strain (Bug River, Poland), established an outgroup of clusters B1 and B2. This strain revealed a unique MLVA-3 profile.
The MST analysis resulted in a star-like organization of the environmental non-O1/O139 serogroup strains from Poland, indicating the existence of a clonal complex (Fig. 2). Clinical O1 13/154 (India), 1014 (Guinea) and 14/Jor (Jordan) strains (key nos. 018, 025, 016, respectively) were situated on the right-hand side of the MST tree, nearer to the Polish strains than the other strains included in this study. Norwegian clinical non-O1/O139 FFIVC136 strain (key no. 247) connects the Polish strains to other V. cholerae isolates by dotted lines, indicating the most probable connection between two types differing by more than two locus variants. The Spanish O1 serogroup strains were related to the V. cholerae strains isolated in an outbreak in Italy/Albania in 1994 (key nos. 172, 173, 179) through 080025/EZ and 080025/FB strains isolated in Ceuta, Spain in 1990 (key nos. 093, 095, respectively). Interestingly, strains imported from Ecuador to Spain (key nos. 101, 102, 103) were connected to two strains isolated from a marsh in Sevilla, Spain in 1991 (key nos. 099, 100). Norwegian environmental non-O1/O139 FFIVC084 strain (ctxA + and tcpA +) (key no. 198) was connected to the Indian clinical O139 FFIVC130 strain (ctxA + and tcpA +) (key no. 242). The latter and the clinical O139 FFIVC131 strain from California (key no. 261) were connected in the MST tree by a thin line, revealing a double character difference.
The Centers for Disease Control and Prevention (CDC) has recently described a large cholera outbreak in Haiti (autumn 2010) . During this outbreak, an increase of travel-associated cholera cases in neighbouring countries was reported, indicating that although cholera outbreaks occurred in areas with poor water and sanitation infrastructure, other countries are also at risk. In addition, CDC classified V. cholerae as a category B agent according to its potential use as a biological weapon [Reference Kortepeter and Parker35]. Public health authorities are increasingly aware of the threat this agent may constitute. Identification and characterization of V. cholerae isolates is crucial for the control of the disease, and subsequent phylogenetic studies are useful for understanding the relationship between strains.
Environmental non-O1/O139 serogroup FFIVC084 strain (ctxA + and tcpA +), clinical O141 serogroup 080025/FR strain (ctxA + and tcpA −) and a large number of environmental non-O1/O139 serogroup strains from Poland (ctxA − and tcpA +), which may constitute a potential danger to human health, have been included in this work. To illustrate this potential risk, two cases of septicaemia caused by V. cholerae non-O1/O139 serogroup, reported in Poland (summer 2006) can be mentioned. The first case was a 49-year-old man, who was found drowned in a lake. Microbiological examination of blood samples revealed a V. cholera infection of non-O1/O139 serogroup. Water samples collected from four different locations in the lake tested positive for a few V. cholerae non-O1/O139 serogroup strains. The second case of V. cholerae septicaemia occurred in a 79-year-old man. The patient was admitted to hospital in summer 2006 with symptoms of high fever, diarrhoea and severe abdominal cramps. Shortly after admission, he developed pneumonia and septicaemia. Laboratory investigation of two blood samples revealed the presence of V. cholerae [Reference Stypulkowska-Misiurewicz, Pancer and Roszkowiak36].
Two separate serious cholera-like cases caused by non-O1/O139 strains (FFIV136 and FFIV137) were reported in Norway [Reference Henriksen37]. Furthermore, in our study the strains showed resistance to several antibiotics, which illustrates that environmental non-O1/O139 isolates are potentially dangerous, and supports the idea that new toxigenic strains could emerge through a lysogenic infection of non-toxigenic V. cholerae strains with the CTXΦ prophage harbouring virulence genes [Reference Waldor and Mekalanos38].
Several variants of CTXΦ prophage are in one or both V. cholerae chromosomes, as a single copy or in multiple tandemly arrayed copies, as a result of integration and excision mechanisms. These mechanisms of genetic exchange contribute to the considerable diversity of V. cholerae strains and, at the same time, they explain the origin of recent epidemic V. cholerae strains [Reference Das, Bischerour and Barre39]. O139 isolates have been suggested to arise by genetic exchange with non-O1/O139 V. cholerae strains, as well as with clinical O1 strains [Reference Faruque40]. The authors of that study pointed out that it seems possible that O139 strains derived from O1 progenitors could have epidemic potential, as opposed to O139 strains derived from non-O1/O139 progenitors. In accord with this study, there is a relationship between O139 FFIVC133 strain (ctxA + and tcpA +) (key no. 244) and clinical O1 serogroup 080025/EZ and 080025/FB strains (ctxA + and tcpA +) (key nos. 093, 095, respectively) (Fig. 2), supporting this hypothesis. The existence of environmental non-O1/O139 V. cholerae strains related to clinical O1 and O139 serogroup strains, as well as the fact that there are virulent clinical non-O1/O139 V. cholerae strains with resistance to multiple antimicrobial agents, highlights the need of continuous surveillance of this pathogen.
Thirteen O1 strains of different geographical origin resulted in an atypical biotype, herein referred to as ‘intermediate’. No hybrid or El Tor variant strains were identified since the scheme proposed by Raychoudhuri et al. [Reference Raychoudhuri6] was not used in our study. This information indicates that the hybrid or El Tor variant strains are more widespread than expected. Discrepancies between the biotypes previously published [Reference Usera25] and biotypes observed in the present study were detected. Five strains isolated in Spain previously biotyped as atypical by Usera et al. [Reference Usera25] have been assessed as El Tor biotype in our study. Additionally, one strain biotyped as El Tor was shown as hybrid biotype in our study. No reasons explaining the phenotypic variations identified through time can be given, although mutations in this strain can be speculated. The V. cholerae strains included in our study fell into four clusters, according to the phenotypic and genetic features analysed by the UPGMA method (Supplementary Fig. S1). The analysis revealed a clustering of V. cholerae strains by clinical or environmental source, and established a relationship among isolates from the same geographical area. Interestingly, our study differentiated the six Moroccan outbreak strains into three various genotypes, previously designated as one genotype by ribotyping, PFGE and multi-locus enzyme electrophoresis [Reference Usera25]. We observed two different genotypes for the three environmental V. cholerae strains isolated in Sevilla (Spain), which had previously been typed as one by ribotyping and PFGE [Reference Usera25]. On the other hand, three pairs of strains (FFIV130 and FFIVC133, FFIVC057 and FFIVC058, FFIVC114 and FFIVC115) had previously not been differentiated based on a six-loci MLVA scheme [Reference Olsen22]. However, in our study, the UPGMA clustering analysis showed similarities of 90%, 93·7% and 90%, respectively, due to differences observed in the biochemical tests and the susceptibility to antimicrobial agents tests. These results indicate that, despite having an identical allelic profile, the strains are carriers of different phenotypic features.
Fifty-six out of 59 non-O1/O139 V. cholera strains isolated from water in Poland over a period of 10 years revealed a unique antimicrobial susceptibility pattern, diverse MLVA-3 profiles, and differences in biochemical pattern. The low level of phenotypic and genetic diversity in the isolates indicated that the Polish isolates may have originated from the same clone. The Polish 52/110/2006 and 8/110/2006 strains (key nos. 062, 010, respectively) (see Supplementary Table 1) isolated from Bug River in 1998 were centrally located in the lower part of the MST. They showed variation in VC5 and VC9 loci, and identical phenotypic profiles. Thus, it can be speculated that several SLV may have evolved from one of these two strains. More heterogeneity was observed in non-Polish strains, with types differing by more than two locus variants. In this case, significant variability in the antimicrobial susceptibility pattern, in the biochemical profile and in the allelic profile was observed by the combined tests performed.
In summary, we have studied different methods for typing V. cholerae strains, either individually or in combination, to obtain an optimal phylogenetic differentiation of this bacterium. The DI estimated from HGDI for individual phenotypic markers (antibiotic susceptibility and biochemical tests) were considerably low (DI=0·610, DI=0·790, respectively). However, when these data were combined with MLVA-3 data, a higher discriminatory level (DI=0·997) was obtained, similar to the previously described six-loci MLVA scheme [Reference Olsen22] or to the seven-loci scheme [Reference Teh, Chua and Thong11]. The 111 V. cholerae strains analysed were organized into 98 different groups based on phenotypic and genetic markers used in combination. Phylogenetic analysis of the combined tests showed a clear discrimination between clinical O1 and O139 serogroup strains and environmental isolates. We conclude that phenotypic tests in addition to genetic tests provide important information for characterization of V. cholerae strains isolated during epidemic and pandemic outbreaks, and are essential when performing phylogenetic studies or forensic trace-back studies of V. cholera strains.
Supplementary material accompanies this paper on the Journal's website (http://journal.cambridge.org/hyg).
This work was part of the European Biodefence Laboratory Network, EBLN (EDA B-0060-ESM4-GC) coordination work on dangerous pathogens, and was supported by funding from the Spanish Ministry of Defence, Polish Ministry of Defence and Norwegian Ministry of Defence. We thank Dr A. Echeita for providing V. cholera strains for ITM collection. We thank Dr J. López for providing V. cholera data of the V. cholerae ITM collection. We thank Dr N. Aboitiz for editorial assistance on the manuscript.
DECLARATION OF INTEREST